Smith & Nephew Reinforces Strong Educational Commitment to Advanced Wound Management at World Union of Wound Healing Societie...
September 21 2016 - 3:00AM
Business Wire
Smith & Nephew (LSE:SN)(NYSE:SNN), the global medical
technology business, highlights three scientific symposia at World
Union of Wound Health Societies (WUWHS) on 25–29 September 2016 in
Florence, Italy. These symposia reinforce Smith & Nephew’s
commitment to supporting healthcare professionals by conducting and
effectively communicating research in areas of clinical practice
that can enable improved outcomes for patients.
The first symposia will focus on PICO™, a unique single-use
negative pressure wound therapy system (sNPWT), and its role in
reducing surgical site complications. Through a wealth of clinical
evidence, PICO™ is rapidly becoming a leading choice in NPWT due to
its ability to manage a wide range of wounds at risk of
complications in a clinical and cost effective way. In a recent
study, using PICO™ reduced superficial surgical complications
four-fold (from 8% to 2%) and significantly reduced the number of
total dressing changes required per patient.1
“Infections can occur at relatively higher than expected rate
among patients associated with co-morbid risk factors who have
surgery, resulting in considerable social, healthcare and wider
economic implications,” says Dr Risal Djohan, Department of
Plastic Surgery, Cleveland Clinic, USA . “The clinical evidence
that will be presented at WUWHS will further demonstrate how PICO™
could potentially shift the treatment paradigm to heal most types
of wounds more efficiently, leading to positive patient
outcomes.”
In Smith & Nephew’s second symposia, a panel of 10 global
scientific and clinical experts will present an evolving consensus
statement, reinforcing the need to better understand the role of
biofilms in delayed wound healing and the challenges it
presents.
Finally, through the third symposia – Pressure Ulcer Prevention:
Driving to Zero – leading experts will discuss prioritising
programmes to significantly reduce hospital-acquired pressure
ulcers.
Dr. Niz Islam, Vice President, Scientific & Medical Affairs,
said “Smith & Nephew is proud to support this important
gathering of the community to share data and new practices in
advanced wound management. We are bringing together wound experts
to present clinically relevant data in symposia on three areas of
importance to the community; NPWT, pressure ulcer prevention
protocols and a consensus expert panel on biofilms. Through these
and other new clinical evidence we aim to improve outcomes for
patients, healthcare professionals and health care systems.”
Smith & Nephew is a diamond sponsor of World Union of Wound
Healing Societies Meeting
About Smith & Nephew’s WUWHS Symposia
Symposia Date / Location
Presenters Pressure Ulcer Prevention: Driving to Zero
27 September 2016
12:15 – 13:15
Hall Brunelleschi
M. Collier (UK), M. Sammon (USA), J. Frumenti (USA)
Surgical
Incision Management:Prevention of Surgical Wound
Complications with Single-Use NPWT (PICO™) 28 September 2016
12:15 – 13:45
Hall Michelangelo
M. Sugrue (IRE), R. Djohan (USA), N. Hyldig (DK),S. Nair (USA)
Wound Biofilm Consensus: Recommendations from an Expert
Panel 29 September 2016
8:30 – 9:30
Hall Donatello
G. Schultz (USA), T. Bjarnsholt (DK), R. Wolcott (USA)
- Ends -
About Smith & Nephew
Smith & Nephew is a global medical technology business
dedicated to helping healthcare professionals improve people's
lives. With leadership positions in Orthopaedic Reconstruction,
Advanced Wound Management, Sports Medicine and Trauma &
Extremities, Smith & Nephew has around 15,000 employees and a
presence in more than 100 countries. Annual sales in 2015 were more
than $4.6 billion. Smith & Nephew is a member of the FTSE100
(LSE:SN, NYSE:SNN).
For more information about Smith & Nephew, please visit our
website www.smith-nephew.com, follow @SmithNephewplc on Twitter or
visit SmithNephewplc on Facebook.com.
For more information on Smith & Nephew’s presence at WUWHS
2016 please visit us at:
http://www.smith-nephew.com/wuwhs2016/.
Forward-looking Statements
This document may contain forward-looking statements that may or
may not prove accurate. For example, statements regarding expected
revenue growth and trading margins, market trends and our product
pipeline are forward-looking statements. Phrases such as "aim",
"plan", "intend", "anticipate", "well-placed", "believe",
"estimate", "expect", "target", "consider" and similar expressions
are generally intended to identify forward-looking statements.
Forward-looking statements involve known and unknown risks,
uncertainties and other important factors that could cause actual
results to differ materially from what is expressed or implied by
the statements. For Smith & Nephew, these factors include:
economic and financial conditions in the markets we serve,
especially those affecting health care providers, payers and
customers; price levels for established and innovative medical
devices; developments in medical technology; regulatory approvals,
reimbursement decisions or other government actions; product
defects or recalls or other problems with quality management
systems or failure to comply with related regulations; litigation
relating to patent or other claims; legal compliance risks and
related investigative, remedial or enforcement actions; disruption
to our supply chain or operations or those of our suppliers;
competition for qualified personnel; strategic actions, including
acquisitions and dispositions, our success in performing due
diligence, valuing and integrating acquired businesses; disruption
that may result from transactions or other changes we make in our
business plans or organisation to adapt to market developments; and
numerous other matters that affect us or our markets, including
those of a political, economic, business, competitive or
reputational nature. Please refer to the documents that Smith &
Nephew has filed with the U.S. Securities and Exchange Commission
under the U.S. Securities Exchange Act of 1934, as amended,
including Smith & Nephew's most recent annual report on Form
20-F, for a discussion of certain of these factors. Any
forward-looking statement is based on information available to
Smith & Nephew as of the date of the statement. All written or
oral forward-looking statements attributable to Smith & Nephew
are qualified by this caution. Smith & Nephew does not
undertake any obligation to update or revise any forward-looking
statement to reflect any change in circumstances or in Smith &
Nephew's expectations.
◊ Trademark of Smith & Nephew. Certain marks registered US
Patent and Trademark Office.
References
1. Karlakki, S. et al. (2016). Incisional negative
pressure wound dressings (NPWTd) in routine primary hip and knee
replacements – A randomised controlled trial. Bone and Joint
Research
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160921005078/en/
MadanoKarley Ura, +44 (0) 20 3595 2415orJaclyn Confalone, +44
(0) 20 3595 2441
Smith and Nephew (NYSE:SNN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Smith and Nephew (NYSE:SNN)
Historical Stock Chart
From Apr 2023 to Apr 2024